Randomized, Placebo-Controlled, Double-Blind Study to Assess Safety, Immunogenicity, and Protective Efficacy of Two Regimens of Radiation Attenuated Plasmodium Falciparum NF54 Sporozoites (PfSPZ Vaccine) During Natural Transmission Season in Healthy African Adults in Mali
Status: Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 11 Sep 2019
Price : $35 *
At a glance
- Drugs Malaria vaccine live attenuated-Sanaria (Primary) ; Artemether/lumefantrine
- Indications Falciparum malaria
- Focus Adverse reactions
- 23 Jul 2019 Planned End Date changed from 30 Jun 2019 to 30 Jun 2020.
- 30 Mar 2019 Status changed from recruiting to active, no longer recruiting.
- 21 Mar 2019 Planned initiation date (estimated date for recruitment of the first subject) changed from 1 Mar 2019 to 27 Mar 2019.